REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 167 filers reported holding REGENXBIO INC in Q3 2019. The put-call ratio across all filers is 1.08 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $366,712 | -15.3% | 22,279 | +2.9% | 0.00% | -33.3% |
| Q2 2023 | $432,943 | +5.2% | 21,658 | -0.5% | 0.00% | 0.0% |
| Q1 2023 | $411,633 | -16.2% | 21,768 | +0.5% | 0.00% | 0.0% |
| Q4 2022 | $491,067 | -14.9% | 21,652 | -0.7% | 0.00% | -25.0% |
| Q3 2022 | $577,000 | +8.3% | 21,813 | +1.0% | 0.00% | 0.0% |
| Q2 2022 | $533,000 | -28.6% | 21,597 | -3.9% | 0.00% | 0.0% |
| Q1 2022 | $746,000 | -4.4% | 22,472 | -5.8% | 0.00% | 0.0% |
| Q4 2021 | $780,000 | -24.4% | 23,860 | -3.1% | 0.00% | -33.3% |
| Q3 2021 | $1,032,000 | +5.3% | 24,612 | -2.4% | 0.01% | +100.0% |
| Q2 2021 | $980,000 | +12.9% | 25,220 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $868,000 | -15.2% | 25,439 | +12.8% | 0.00% | -25.0% |
| Q4 2020 | $1,023,000 | +60.8% | 22,551 | -2.5% | 0.00% | +33.3% |
| Q3 2020 | $636,000 | -27.6% | 23,120 | -3.1% | 0.00% | -25.0% |
| Q2 2020 | $879,000 | +19.3% | 23,854 | +4.8% | 0.00% | 0.0% |
| Q1 2020 | $737,000 | -24.8% | 22,765 | -4.8% | 0.00% | 0.0% |
| Q4 2019 | $980,000 | +12.3% | 23,908 | -2.5% | 0.00% | 0.0% |
| Q3 2019 | $873,000 | -31.3% | 24,520 | -0.9% | 0.00% | -20.0% |
| Q2 2019 | $1,270,000 | -7.9% | 24,731 | +2.8% | 0.01% | 0.0% |
| Q1 2019 | $1,379,000 | +33.2% | 24,062 | -2.4% | 0.01% | +25.0% |
| Q4 2018 | $1,035,000 | -44.2% | 24,664 | +0.3% | 0.00% | -33.3% |
| Q3 2018 | $1,856,000 | +18.6% | 24,589 | +12.7% | 0.01% | +20.0% |
| Q2 2018 | $1,565,000 | +194.7% | 21,814 | +22.7% | 0.01% | +150.0% |
| Q1 2018 | $531,000 | -13.8% | 17,776 | -4.1% | 0.00% | 0.0% |
| Q4 2017 | $616,000 | +1.3% | 18,538 | +0.5% | 0.00% | 0.0% |
| Q3 2017 | $608,000 | +80.4% | 18,451 | +8.1% | 0.00% | +100.0% |
| Q2 2017 | $337,000 | +39.8% | 17,071 | +36.9% | 0.00% | 0.0% |
| Q1 2017 | $241,000 | +11.6% | 12,468 | +7.1% | 0.00% | 0.0% |
| Q4 2016 | $216,000 | -99.9% | 11,646 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $163,595,000 | +75.4% | 11,677 | +0.1% | 0.00% | – |
| Q2 2016 | $93,280,000 | +107.3% | 11,660 | +178.4% | 0.00% | – |
| Q1 2016 | $45,000,000 | – | 4,188 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RTW INVESTMENTS, LP | 1,459,128 | $110,164,000 | 6.60% |
| ArchPoint Investors | 224,187 | $16,926,000 | 4.60% |
| Redmile Group, LLC | 1,656,065 | $125,033,000 | 3.85% |
| WS MANAGEMENT LLLP | 954,812 | $72,088,000 | 2.37% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 342,000 | $25,821,000 | 1.19% |
| Perceptive Advisors | 470,672 | $35,536,000 | 0.95% |
| Pier Capital, LLC | 94,492 | $7,134,000 | 0.90% |
| Ipswich Investment Management Co., Inc. | 29,932 | $2,260,000 | 0.76% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 275,000 | $20,763,000 | 0.74% |
| Timpani Capital Management LLC | 27,835 | $2,102,000 | 0.61% |